This invention relates to an aerated dairy product including a base containing recombined milk and a method for manufacturing the same and further relates to a dairy product including recombined milk and a milk-based retentate and a method of manufacturing same.

This invention relates to an aerated dairy product including a base containing recombined milk and a method for manufacturing the same and further relates to a dairy product including recombined milk and a milk-based retentate and a method of manufacturing same.

Charged ultrafiltration membranes are synthesized by thermally initiated free-radical polymerization of sodium styrene sulfonate in the pores of an ultrafiltration pre-cursor membrane. The resulting grafted chains of the charged UF membrane provide significant negative charge to maintain nearly complete rejection of proteins at significantly higher flux.

Charged ultrafiltration membranes are synthesized by thermally initiated free-radical polymerization of sodium styrene sulfonate in the pores of an ultrafiltration pre-cursor membrane. The resulting grafted chains of the charged UF membrane provide significant negative charge to maintain nearly complete rejection of proteins at significantly higher flux.

Disclosed herein are methods and compositions including casein, and methods for making these compositions.

Disclosed are methods for preparing dairy compositions using a final nanofiltration step. Generally, the methods also include an ultrafiltration step and a reverse osmosis step, and optionally, a diafiltration step.

Disclosed herein are methods and compositions including casein, and methods for making these compositions.

The present disclosure provides a human milk fortifier product composition with, a protein component in the milk fortifier in an amount ranging from 6 wt/wt % to 35 wt/wt % on solids basis; a fat component in the in the milk fortifier in an amount ranging from 0.1 wt/wt % to 36 wt/wt % on solids basis; a carbohydrate in the milk fortifier selected from the group of Lactose and Oligosaccharides present in the in an amount from 25 wt/wt % to 75 wt/wt % on solids basis; small molecules consisting of Oligosaccharides in the human milk fortified by the said fortifier is at least 25% more than the human milk alone. The majority of small molecules consisting of Vitamin A, Vitamin D, Vitamin E, LCPUFA, Epidermal growth factor and many others are retained in the fortifier product.

Disclosed are baby formula compositions and methods of making thereof. In some embodiments, the baby formula composition includes goat milk and a variety of other nutritional components. In some embodiments, the baby formula composition is provided as a powder, to be mixed with water and fed to a baby or toddler. In some embodiments, the baby formula composition is suitable for babies at least 12 months in age or older.